… generated the first iPSC lines from people with Progressive Multiple Sclerosis and developed protocols to create key … and microglia — as well as brain organoids and co-culture systems. Dr. Fossati also sent the first patient-derived …

… of amyloid, tau, dopamine cell loss and regional atrophy to cognition and disease course in PD and DLB, and …

… of a drug that inhibits synapse and neuronal loss, brain atrophy, cognitive impairment and the hallmark brain …

… acid esters are also currently being tested clinically for multiple sclerosis and psoriasis (in fact, they’ve been … been shown to have adverse effects on the gastrointestinal system in previous clinical trials, but early pre-clinical …

… his current research focuses on human corticospinal (brain system) physiology (function), particularly brainstem and … numerous awards for his scientific achievements, including multiple awards from international institutions. …

… disease with deficits in motor, sleep, cognitive, and other systems, we propose to establish a “platform” of models to … in combination with levodopa may improve PD treatment in multiple ways. During the day, MLR-1017 administration would …  MLR-1017 showed both behavioral and biochemical benefit in multiple experiments that modeled Parkinson’s-like symptoms. …